CARD: A Contact-based Architecture for Resource Discovery in Wireless Ad Hoc Networks

Traditional protocols for routing in ad hoc networks attempt to obtain optimal or shortest paths, and in doing so may incur significant route discovery overhead. Such approaches may be appropriate for routing long-lived transfers where the initial cost of route discovery may be amortized over the life of the connection. For short-lived connections, however, such as resource discovery and small transfers, traditional shortest path approaches may be quite inefficient. In this paper we propose a novel architecture, CARD, for resource discovery in large-scale wireless ad hoc networks. Our mechanism is suitable for resource discovery as well as routing very small data transfers or transactions in which the cost of data transfer is much smaller than the cost of route discovery. Our architecture avoids expensive mechanisms such as global flooding and complex hierarchy formation and does not require any location information. In CARD resources within the vicinity of a node, up to a limited number of hops, are discovered using a proactive scheme. For resources beyond the vicinity, each node maintains a few distant nodes called contacts. Contacts help in creating a small world in the network and provide an efficient way to query for distant resources. Using contacts, the network view (or reachability) of the nodes increases, reducing the discovery overhead and increasing the success rate. On the other hand, increasing the number of contacts also increases control overhead. We study such trade-off in depth and present mechanisms for contact selection and maintenance that attempt to increase reachability with reduced overhead. Our schemes adapt gracefully to network dynamics and mobility using soft-state periodic mechanisms to validate and recover paths to contacts. Our simulation results show that CARD is scalable and can be configured to provide desirable performance for various network sizes. Comparisons with other schemes show overhead savings reaching over 93% (vs. flooding) and 80% (vs. bordercasting or zone routing) for high query rates in large-scale networks.     

Hpcfolder: a simple tool used to parallelize algorithms using the message passing interface (MPI)

The Journal of Supercomputing - Hpcfolder is a user-friendly high-performance computing tool that can be used to analyze the performance of algorithms parallelized using MPI. It is possible to view...     

A new organic electrooptic crystal:2,6-dibromo-N-methyl-4-nitroaniline (DBNMNA)

A new organic electrooptic crystal, 2,6-dibromo-N-methyl-4-nitroaniline, is reported. The crystal structure was determined by X-ray diffraction (orthorhombic, space group Fdd2, point group mm2, Z=16, a=11.745 Å, b=29.640 Å, c=10.807 Å). The refractive indexes were measured at several wavelengths between 500 and 1100 nm (at 632.8 nm, n_a=1.90, n_b=1.62, and n_c=1.48) and fit the data to a single oscillator Sellmeier equation. A report is presented on measurements of the linear electrooptic effect, yielding the combined coefficients n_a ³r₁₃-n_c³ r₃₃, as well as the first known measurements of the quadratic electrooptic effect in an organic crystal, yielding the coefficients r₄₂ and r₅₁ at 514.5, 632.8, and 810 nm. Good agreement is found between the observed dispersion in the electrooptic coefficients and that predicted by the simple two-level dispersion model     

Pharmacokinetics and safety of tobramycin after once-daily administration in patients with cystic fibrosis

STUDY OBJECTIVE: Tobramycin is commonly used to treat respiratory tract infections in patients with cystic fibrosis. We designed a study to determine the pharmacokinetics and safety of once-daily dosing of tobramycin in this population. DESIGN: Multiple blood samples were collected from each patient, and serum concentrations of tobramycin were determined by a fluorescence polarization immunoassay. Blood urea nitrogen and serum creatinine levels were measured every 2 to 3 days, and audiometric evaluations were performed at the start and end of therapy. MEASUREMENTS AND RESULTS: Eighteen patients (mean age, 24.6 years) received tobramycin at doses of 7 to 15 mg/kg/d as a single-dose infusion over 20 min. The maximum serum concentration of tobramycin ranged from 40.1 to 64.6 mg/L. A mean dose of 11.9+/-1.9 mg/kg was needed to obtain a theoretical mean peak serum concentration of 42.4+/-4.5 mg/L. The mean total body clearance, apparent volume of distribution, and elimination half-life was 1.7+/-0.4 mL/min/kg, 0.27+/-0.06 L/kg, and 1.8+/-0.3 h, respectively. The period of time that the serum concentration exceeded eight times the theoretical minimum inhibitory concentration of 1 mg/L ranged from 2.1 to 4.4 h, which was nearly five times longer compared with the use of divided daily doses in the same patients during previous hospitalizations. No nephrotoxicity, ototoxicity, or adverse effects occurred in any patient. CONCLUSION: Based on our data, tobramycin may be used safely in once-daily doses to treat exacerbations of respiratory tract infections in patients with cystic fibrosis.     

Stability of enalapril maleate in three extemporaneously prepared oral liquids

The stability of enalapril 1 mg/mL (as the maleate) in deionized water, citrate buffer solution, and a sweetened suspending agent at two temperatures was studied. Twenty enalapril 10-mg tablets were crushed to a powder. Deionized water, citrate buffer solution, or sweetened vehicle was added to produce three 200-mL batches of each liquid; the expected final concentration of enalapril in each was 1 mg/mL. Each formulation was stored in 10 60-mL bottles, 5 of which were stored at 4 degrees C and 5 at 25 degrees C. Samples were collected on days 0, 7, 14, 28, 42, 56, 70, and 91 for visual inspection and analysis by high-performance liquid chromatography; pH was measured at each sampling time as well. The mean concentration of enalapril in the three liquids at 4 degrees C was > 94% of the initial concentration throughout the 91-day study period. At 25 degrees C, the mean concentration of enalapril was > 90% for 56 days and > 92% for 91 days in both citrate buffer solution and sweetened vehicle. The pH of the liquid prepared with deionized water and stored at 25 degrees C decreased by 2.0 pH units. Enalapril 1 mg/mL (as the maleate) in three extemporaneously compounded oral liquids was stable for 91 days at 4 and 25 degrees C with the exception of enalapril in deionized water, which was stable for only 56 days at 25 degrees C.     

Deeper into the (infra)red

Generation and coherent electro-optic detection of far-infrared and mid-infrared radiation enable new capabilities compared to photoconductive detection techniques     

Efficacy of itraconazole in children with Trichophyton tonsurans tinea capitis

The microbiology of needle aspirates from 40 inflamed cervical lymph glands was studied for aerobic and anaerobic bacteria, fungi and mycobacteria. Forty-two bacterial, 11 mycobacterial and six fungal isolates were isolated. Aerobic bacteria only were recovered in 11 (27.5%), anaerobes alone in five (12.5%) and mixed aerobic and anaerobic bacteria in seven (17.5%). Mycobacterium sp. were recovered in 11 (27.5%) and fungi in six (15%). The recovery of anaerobes was associated with dental infection. Eighteen aerobic bacteria were isolated and the predominant ones were Staphylococcus aureus (eight isolates) and group A streptococci (four). Twenty-four anaerobic bacteria were recovered and the predominant ones were: Prevotella sp. (six), Peptostreptococcus sp. (five), Propionibacterium acnes (four) and Fusobacterium sp. (three). These findings demonstrate the role of anaerobic organisms in cervical lymphadenitis and the need to culture aspirated material from the glands for both aerobic and anaerobic microorganisms.